Sort
82,697 grants matching “vaccine development”
Advanced Development of a Multivalent Vaccine Candidate for Filovirus and Lassa Fever
$6,964,520Jeffrey Meshulam · Profectus Biosciences, Inc. · N01 · FY2017 · AI
COVID Protection After Transplant (CPAT) Multicenter Adaptive Trial
$6,941,821Christine Marie Durand · Johns Hopkins University · U01 · FY2021 · AI
ATN Coordinating Center
$6,937,007Craig M Wilson · University Of Alabama At Birmingham · U01 · FY2009 · HD
The UNC/Emory Center for Innovative Technology (iTech) across the prevention and care continuum
$6,914,400Lisa B Hightow-Weidman · Univ Of North Carolina Chapel Hill · U19 · FY2019 · HD
The Southwest National Primate Research Center
$6,909,858Kenneth Parkhurst Trevett · Texas Biomedical Research Institute · P51 · FY2009 · RR
Vaccine Immunology Program
$6,901,965Richard A Koup · National Institute Of Allergy And Infectious Diseases · ZIA · FY2025 · AI
COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTER: CLINICAL CORE
$6,899,386Emmanuel Walter · Duke University · N01 · FY2020 · AI
MALARIA VACCINE PRODUCTION AND SUPPORT SERVICES
$6,899,135Kathleen Kootz · Science Applications International Corp · N01 · FY2011 · AI
Malaria Vaccines: Pfs25-rEPA and Pfs230-rEPA
$6,889,173Patrick Duffy · National Institute Of Allergy And Infectious Diseases · ZIA · FY2024 · AI
Characterizing pediatric genomes through an optimized sequencing approach
$6,883,364Shawn E Levy · Hudson-Alpha Institute For Biotechnology · U24 · FY2021 · HD
Project 2: Viral entry, antibodies, and structural biology
$6,871,666David Veesler · University Of Washington · U19 · FY2024 · AI
Leadership for HIV/AIDS Clinical Trials Networks; HIV Prevention Trials Network
$6,867,620Deborah J Donnell · Fred Hutchinson Cancer Research Center · U01 · FY2008 · AI
Dengue Human Immunology Project Consortium (DHIPC)
$6,860,460Ana Fernandez-Sesma · Icahn School Of Medicine At Mount Sinai · U19 · FY2017 · AI
ADVANCED DEVELOPMENT OF A VACCINE FOR PANDEMIC AND PRE-EMERGENT CORONAVIRUSES
$6,858,237Kevin Saunders · Duke University · N01 · FY2023 · AI
LC: HIV PREVENTION TRIALS NETWORK
$6,848,077Susan H Eshleman · Johns Hopkins University · UM1 · FY2022 · AI
ATN Coordinating Center
$6,833,921Craig M Wilson · University Of Alabama At Birmingham · U01 · FY2009 · HD
CENTRAL LABORATORY FOR THE HIV VACCINES TRIALS NETWORK
$6,830,635Duke University · U01 · FY2000 · AI
Middle Atlantic Regional Center for Excellence for Biodefense and Emerging Infect
$6,823,026Myron Max Levine · University Of Maryland Baltimore · U54 · FY2013 · AI
Establishment of the New York University Vaccine and Treatment Evaluation Unit (NYU VTEU)
$6,820,430Mark Joseph Mulligan · New York University School Of Medicine · UM1 · FY2021 · AI
The UNC/Emory Center for Innovative Technology (iTech) across the prevention and care continuum
$6,814,055Sarah E. Rutstein · Univ Of North Carolina Chapel Hill · U19 · FY2020 · HD
HIV Vaccine Research and Development - NIAID DAIDS Therapeutics Research Program
$6,808,985National Institute Of Allergy And Infectious Diseases · Y01 · FY2025 · AI
A prospective study of critical environmental exposures in formative early life that impact lifelong health in rural US children: the New Hampshire Birth Cohort Study
$6,808,363Margaret Rita Karagas · Dartmouth College · UG3 · FY2023 · OD
HIV/AIDS Vaccine Development
$6,804,629Gary J Nabel · National Institute Of Allergy And Infectious Diseases · ZIA · FY2010 · AI
Prototype strategy for vaccines and antibodies to Peribunyaviridae
$6,793,772Sean P. J. Whelan · Washington University · U19 · FY2024 · AI
Advanced Development of a Multivalent Vaccine Candidate for Filovirus and Lassa Fever
$6,784,550Matthias Schnell · Thomas Jefferson University · N01 · FY2019 · AI